Sudarshan Sukhani of Technical Trends is of the view that one should avoid Aurobindo Pharma.
first published: Nov 22, 2011 06:35 pm
A collection of the most-viewed Moneycontrol videos.

Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell

Why This Tenant Says Bandra Is Better Than California | The Tenant

Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live

LIVE: RBI Governor Sanjay Malhotra Delivers Key Monetary Policy Statement | Interest Rates & Outlook
You are already a Moneycontrol Pro user.

